Hydrogen Sulfide Regulation in Cardioprotection
Hydrogen Sulfide Regulation in Cardioprotection
批准号:
10610727
负责人:
DAVID JOSEPH LEFER
金额:
$54.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-11 至 2025-04-30
关键词:
AddressAttenuatedBiologicalBiological AvailabilityBiological ModelsBiological ProcessBiologyCardiovascular DiseasesCardiovascular systemChemicalsClinicalCytoprotectionDetectionDevelopmentDiabetes MellitusDiseaseDisease modelEvaluationExhibitsFluorescent ProbesFunctional disorderFutureGasesGoalsHeart DiseasesHeart failureHydrogen SulfideHypertensionImageInflammationKineticsKnowledgeLaboratoriesLibrariesLinkLiquid substanceMediatingMethodsModelingMonitorMyocardial InfarctionMyocardial IschemiaMyocardial Reperfusion InjuryOxidation-ReductionPathologicPeripheral Vascular DiseasesPharmacologyPhysiologyPlayProtocols documentationReactionRegulationReportingResearchRoleSamplingSeriesSignaling MoleculeSodium ChlorideSourceTherapeuticTimeTissuesVasodilationcardioprotectionclinically relevantdetection methodfluorophoreimprovednoveloxidationsensorsodium sulfidethioestertool
中文摘要
项目摘要
硫化氢(H2S)是一种重要的信号分子,具有强的细胞保护作用
对心血管系统的作用。目前的结果表明,H2S水平的调节
可能对许多疾病状态具有潜在的治疗价值,
抗炎、抗氧化。然而,确切的作用机制仍然是
不清楚和实际的H2S浓度/流量需要表现出最佳的保护,
这些疾病模型有待确定。这种知识的缺乏是一个主要的负担
H2S疗法的发展。为了解决这个问题,研究可以
需要有效地检测H2S并特别地提供/除去生物样品中H2S。
在此应用中,我们计划开发用于H2S检测的高灵敏度荧光探针。
我们还将开发新型H2S释放剂和清除剂。新
化学品将用于确定最佳的H2S配置文件的心脏保护模型,
心肌缺血/再灌注(MI/R)损伤和心力衰竭。这项研究将建立
指导H2S治疗发展的有用协议。
英文摘要
Project Summary
Hydrogen sulfide (H2S) is an important signaling molecule with potent cytoprotective
actions in cardiovascular systems. Current results indicate that modulation of H2S levels
could have potential therapeutic value for a number of disease states such as vasodilation,
anti-inflammation, and anti-oxidation. However, the exact mechanisms of action are still
unclear and the actual H2S concentration/flux needed to exhibit the optimal protection in
those disease models are to be determined. This lack of knowledge presents a major burden
in the development of H2S based therapy. To solve this problem, research tools that can
effectively detect H2S and specifically supply/remove H2S in biological samples are needed.
In this application we plan to develop highly sensitive fluorescent probes for H2S detection.
We will also develop novel H2S releasing agents and scavenging agents. The new
chemicals will be used to determine the optimal H2S profiles for cardioprotection in models of
myocardial ischemia/reperfusion (MI/R) injury and heart failure. This study will establish
useful protocols guiding the development of H2S therapy.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10391506
-
项目类别:
-
资助金额:$56.2万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10162413
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
-
批准号:10077584
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2019
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Mitochondrial DNA Repair Enzyme for Heart Failure
-
批准号:9408031
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2017
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel antifibrotic small molecules for the treatment of heart failure
-
批准号:9142025
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2016
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8629076
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8889814
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8289582
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7900081
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8835549
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8399050
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7754425
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8921357
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8085943
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8207216
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7742542
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7599368
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8011098
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES
-
批准号:6184820
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1999
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Mechanism of Myocardial Reperfusion Injury in Diabetes
-
批准号:6998480
-
项目类别:
-
资助金额:$24.23万
-
财政年份:1999
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
海外基金